ZA939718B - Process for production of cell cultures with elevated content of endogenous cytokines - Google Patents

Process for production of cell cultures with elevated content of endogenous cytokines

Info

Publication number
ZA939718B
ZA939718B ZA939718A ZA939718A ZA939718B ZA 939718 B ZA939718 B ZA 939718B ZA 939718 A ZA939718 A ZA 939718A ZA 939718 A ZA939718 A ZA 939718A ZA 939718 B ZA939718 B ZA 939718B
Authority
ZA
South Africa
Prior art keywords
cell cultures
production
elevated content
endogenous cytokines
blood
Prior art date
Application number
ZA939718A
Other languages
English (en)
Inventor
Horst Dr Med Kief
Original Assignee
Horst Dr Med Kief
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6476762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA939718(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Horst Dr Med Kief filed Critical Horst Dr Med Kief
Publication of ZA939718B publication Critical patent/ZA939718B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA939718A 1992-12-29 1993-12-28 Process for production of cell cultures with elevated content of endogenous cytokines ZA939718B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4244437A DE4244437A1 (de) 1992-12-29 1992-12-29 Verfahren zur Gewinnung körpereigener Zytokine

Publications (1)

Publication Number Publication Date
ZA939718B true ZA939718B (en) 1994-08-29

Family

ID=6476762

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939718A ZA939718B (en) 1992-12-29 1993-12-28 Process for production of cell cultures with elevated content of endogenous cytokines

Country Status (8)

Country Link
EP (1) EP0607593B1 (xx)
JP (1) JPH0787965A (xx)
AT (1) ATE196088T1 (xx)
AU (1) AU672449B2 (xx)
CA (1) CA2112314A1 (xx)
DE (2) DE4244437A1 (xx)
ES (1) ES2151895T3 (xx)
ZA (1) ZA939718B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19903876B4 (de) * 1999-02-01 2006-09-28 Orthogen Gentechnologie Gmbh Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten
US6303154B1 (en) 1999-09-24 2001-10-16 Boris Breivogel Chemical alteration of mammal urine and mammal blood
JP2003531175A (ja) * 2000-04-26 2003-10-21 ブライフォーゲル ボリス 哺乳動物の尿および血液の化学的変性
EP1555026A3 (en) * 2000-04-26 2005-12-07 Breivogel, Boris Chemical modification of mammalian blood
DE102006005016A1 (de) * 2006-02-03 2007-08-16 Orthogen Ag Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung
EP2120975B1 (de) * 2006-12-22 2015-09-23 Horst Kief Vollblutkulturen mit stimulierten immunzellen und deren verwendung als heilmittel
EP2829278A1 (de) 2013-07-23 2015-01-28 Scientific BioTech GmbH Serum zur Behnandlung von Krankheiten
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2017618B3 (es) * 1986-10-30 1991-03-01 Horst Kief Procedimiento para producir sustancias que tengan sus germenes matados o que estan debilitadas en su virulencia, asi como el empleo de las mismas
CA2015294A1 (en) * 1989-04-28 1990-10-28 John J. Rinehart Generation and expansion of lak cells

Also Published As

Publication number Publication date
EP0607593A3 (de) 1994-12-14
ATE196088T1 (de) 2000-09-15
CA2112314A1 (en) 1994-06-30
DE59310100D1 (de) 2000-10-12
EP0607593A2 (de) 1994-07-27
ES2151895T3 (es) 2001-01-16
EP0607593B1 (de) 2000-09-06
AU5279093A (en) 1994-07-14
DE4244437A1 (de) 1994-07-28
JPH0787965A (ja) 1995-04-04
AU672449B2 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
DE68909667D1 (de) Fermentationsverfahren und -apparat.
HUT47977A (en) Polipeptides, process for their production and process for production of medical compositions containing such active substances
PT85285A (en) Process for producing il-6 and of pharmaceutical compositions containing the same
DE3588095T2 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
EP0535928A3 (en) Process for producing intermediates for use in production of alkoxyiminoacetamides and intermediates to be used therein
ZA939718B (en) Process for production of cell cultures with elevated content of endogenous cytokines
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
EP0294028A3 (en) Fluoxetine useful for the treatment of diabetes
DE69427955T2 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
ES2060008T3 (es) Produccion de peroxido de hidrogeno.
AU587144B2 (en) Use of medetomidine compounds for treatment of anxiety disorders
ATE61793T1 (de) Aminosaeureester von cycloaliphatischen alkoholen, verfahren zur herstellung und verwendung als arzneimittel.
DK533785A (da) Fedtsyreestere til anvendelse i kosmetiske produkter og fremgangsmaade til fremstilling af saadanne estere
AU678343B2 (en) Method and composition for determining the immunological activity of bioactive substances
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE3884741T2 (de) Mikrobiologisches Verfahren zur Herstellung von UK-61.689 und Mikroorganismen zur Verwendung darin.
EP0288203A3 (en) Immobilised cells
DE69019431T2 (de) Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
ATE69268T1 (de) Verfahren zur herstellung von 4-androsten-3, 17- dion und 1,4-androstadien-3,17-dion.
JPS57181695A (en) Production of heterophile antibody
ATE58124T1 (de) Verfahren zur herstellung von 2,2-dimethyl-3formylcyclopropancarbonsaeurepentafluorphenylmethylester, und seine verwendung bei der herstellung von pestiziden produkten.